Tags:AlternativeDevelopmentEngineeringHealthOilPharmacyProductResearchWebsiteWellness
Constance Therapeutics is a vertically integrated medicinal cannabis company producing standardized and science-based whole plant cannabis extracts. The company has created a new category of whole plant cannabis extracts that provides additional treatment options and fills the gap between traditional pharmaceuticals and commonplace cannabis products. Constance Therapeutics’ extracts are produced from fully trimmed, female unfertilized cannabis sativa flowers of plants with known genetics using certified-organic, pharmaceutical-grade ethanol via a tightly-controlled, quantitatively-defined and patent-pending process that is based on scientific and engineering principles. Each lot of extracts is third party tested and routinely cross-tested in the industry’s most respected laboratories. Since 2008, the company has employed stringent, science-based processes and standards to ensure the highest quality and purity. Headquartered in San Francisco, California, Constance Therapeutics’ cannabis extracts are available exclusively for therapeutic use and can only be purchased by registered California patients, in keeping with Proposition 215, and California Senate Bill 420.
Location: United States, California
Member count: 11-50
Total raised: $4.24748M

Investors 1

DateNameWebsite
-Big Rockbig-rock.c...

Funding Rounds 1

DateSeriesAmountInvestorsDeal News
23.02.2018-$4.24748M--